Skip to main content

Table 1 Sequence results and clinicopathological information of chondrosarcomas used for metabolomics analysis

From: Mutant IDH and non-mutant chondrosarcomas display distinct cellular metabolomes

Genotype Mutation Tumor grade Chondrosarcoma subtype Metastatic status Recurrence
IDH1/2-WT WT 2 Central No Metastasis No
IDH1/2-WT WT 2 Central No Metastasis No
IDH1/2-WT WT 2 Central No Metastasis No
IDH1/2-WT WT 1 Central No Metastasis No
Mutant IDH1 R132C 3 Central Later Metastasis Yes
Mutant IDH1 R132C 3 Central Later Metastasis Yes
Mutant IDH1 R132C 2 Central No Metastasis No
Mutant IDH1 R132C 3 Central No Metastasis No
Mutant IDH1 R132G 1 Clear Cell Later Metastasis Yes
Mutant IDH1 R132G 2 Dedifferentiated Later Metastasis Yes
Mutant IDH1 R132H 3 Clear Cell Metastasis at Presentation No
Mutant IDH1 R132H 3 Dedifferentiated Metastasis at Presentation No
Mutant IDH2 R172G 3 Dedifferentiated Later Metastasis Yes
Mutant IDH2 R172M 3 Dedifferentiated Metastasis at Presentation No
Mutant IDH2 R172M 3 Dedifferentiated Metastasis at Presentation No
Mutant IDH2 R172S 3 Dedifferentiated Later Metastasis Yes
Mutant IDH2 R172S 3 Dedifferentiated Metastasis at Presentation No